Bottom line
What is GMVRX's expense ratio?
GMVRX's expense ratio is 1.42%, or about $142 a year on every $10,000 invested. That is more expensive than 85% of mid-cap funds we track (median 0.88%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Dec 29, 2025
GMVRX fee table
| Net expense ratio | 1.42% |
|---|---|
| Gross expense ratio | 1.7% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.4% |
| Fee waiver / reimbursement | -0.28% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 29, 2025
What GMVRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| GMVRX | $145 | $508 | $897 | $1,985 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.42% expense ratio costs roughly $75,800 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).